Welcome to our dedicated page for Align Technology SEC filings (Ticker: ALGN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Invisalign case shipments, doctor adoption rates, and 3-D printing costs are buried deep inside Align Technology’s SEC filings. If you need to know when margins shift or executives trade stock, scrolling through hundreds of pages isn’t efficient.
Stock Titan decodes Align Technology SEC documents in real time. Our AI reads every 10-K and 10-Q the moment they hit EDGAR, then delivers concise explanations of clear-aligner revenue trends, iTero scanner growth, and supply-chain updates. Natural-language answers—like “Align Technology quarterly earnings report 10-Q filing” or “Align Technology proxy statement executive compensation”—surface instantly, so you spend minutes, not hours, extracting what matters.
All filing types are covered and linked to practical tasks investors run every day:
- Monitor Align Technology insider trading Form 4 transactions and receive Align Technology Form 4 insider transactions real-time alerts before markets open.
- Compare segment profitability with our summary of each Align Technology annual report 10-K simplified.
- Track Invisalign volume guidance via Align Technology 8-K material events explained.
- Dive into board pay packages inside the latest Align Technology proxy statement executive compensation.
Whether you’re understanding Align Technology SEC documents with AI or seeking quick Align Technology earnings report filing analysis, our platform translates technical language, highlights key risk factors, and flags footnotes that move the stock. Make decisions confidently with AI-powered summaries, expert commentary, and up-to-the-minute disclosure feeds—all in one place.
Align Technology (ALGN) reported Q3 results with net revenues of $995.7 million and net income of $56.8 million. Diluted EPS was $0.78 versus $1.55 a year ago as costs rose and one‑time items weighed on results.
Gross profit was $639.2 million on cost of net revenues of $356.5 million. Operating expenses were $542.9 million, including $31.8 million of restructuring and other charges. The quarter also included a $23.1 million impairment on assets held for sale and a $14.9 million inventory impairment. Effective tax rate was 40.1%.
By segment, Clear Aligner revenue was $805.8 million and Systems & Services was $189.9 million. Geographically, revenue was $410.6 million in the U.S., $210.8 million in Switzerland, and $374.3 million in other international markets.
Cash and cash equivalents were $1.00 billion, deferred revenues totaled $1.38 billion, and shares outstanding were 71,749,995 as of October 29, 2025. Year‑to‑date, the company repurchased $371.6 million of stock and has $928.4 million remaining under the April 2025 authorization. Align paid $31.75 million into escrow for a preliminarily approved settlement.
Align Technology furnished an 8-K under Item 2.02 announcing it issued a press release and will hold a conference call regarding its financial results for the third quarter ended September 30, 2025. The press release is included as Exhibit 99.1, and a Cover Page Interactive Data File is embedded as Exhibit 104. The company notes this information is being furnished, not filed, under the Exchange Act.
Align Technology (ALGN) Q2 2025 10-Q highlights:
- Revenue: $1.01 bn, -1.6% YoY; Clear Aligner -3.3%, Systems & Services +5.6%.
- Margin: Gross margin 70.0% (70.2% LY); operating margin 16.1% vs 14.3% on lower legal costs.
- Earnings: Net income $124.6 m (+29%), diluted EPS $1.72 (+34%). Six-month EPS $2.98 (+11%).
- Cash & Liquidity: Cash & equivalents $901 m (-14% YTD); no debt; operating cash flow $181 m (-4%).
- Capital return: Completed $1 bn Jan-23 buyback; repurchased 1.34 m shares for $225 m in H1; new $1 bn Apr-25 program with $200 m OMR slated for H2.
- Share count: 72.5 m outstanding (-3.5% YoY).
- Legal/one-offs: Recorded $4.2 m additional accrual toward $31.75 m Section-1 antitrust settlement (prelim approval 5/28/25); VAT dispute with UK HMRC refunded ~$100 m but subject to appeal.
- Segment profit: Clear Aligner op-profit $267 m (-11%); Systems & Services $86 m (+21%).
- Balance sheet: Inventories $243.8 m (-4% YTD); goodwill now $491 m after Cubicure acquisition.
- Tax: Effective rate 28.2% vs 32.9%.
Key takeaways: Despite modest top-line contraction, disciplined expense control, share buybacks and favorable other income drove double-digit EPS growth. Cash burn and continuing legal/tax uncertainties temper outlook, but new $1 bn authorization reinforces management’s confidence.
FAQ
What is the current stock price of Align Technology (ALGN)?
What is the market cap of Align Technology (ALGN)?
